NCT04810143View on ClinicalTrials.gov

Tacrolimus Microsampling

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

January 3, 2022

Study Completion Date

July 28, 2022

Conditions
Validate Volumetric Absorptive Microsampling (VAMS) Assay
Interventions
DEVICE

Mitra Microsampler

an FDA Class I medical device for direct specimen collection of blood or other biological fluids

Trial Locations (1)

45229

Cincinnati Children's Hospital, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT04810143 - Tacrolimus Microsampling | Biotech Hunter | Biotech Hunter